BZYR - BURZYNSKI RESEARCH INSTITUTE INC
0.0203
-0.002 -11.823%
Share volume: 8,218
Last Updated: 03-27-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.05%
PREVIOUS CLOSE
CHG
CHG%
$0.02
0.00
-0.11%
View ratios
| Fiscal Date | 05-31-2025 | 08-31-2025 | 11-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2026 | Q3 2026 | |
| Report Date | 07-15-2025 | 10-14-2025 | 01-13-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 331.451 K | 333.867 K | 328.862 K | |
| Selling general and admin | 61.179 K | 78.750 K | 68.062 K | |
| Research and development | 270.272 K | 255.117 K | 260.800 K | |
| Total expenses | 331.451 K | 333.867 K | 328.862 K | |
| 0.73% | -1.50% | |||
| Operating income | -331.451 K | -333.867 K | -328.862 K | |
| Ebit | -331.451 K | -333.867 K | -328.862 K | |
| Pretax income | -331.451 K | -333.867 K | -328.862 K | |
| 0.73% | -1.50% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -331.451 K | -333.867 K | -328.862 K | |
| -0.73% | 1.50% |